Cutaneous mucormycosis: report of five cases and review of the literature
Summary Mucormycosis is a highly aggressive fungal infection caused by Zygomycetes, from the order of Mucorales. This infection commonly presents an aggressive and rapid course and typically affects immunocompromised patients. Mucormycosis can manifest in different clinical patterns and locations. A...
Gespeichert in:
| Veröffentlicht in: | Journal of plastic, reconstructive & aesthetic surgery reconstructive & aesthetic surgery, 2009-11, Vol.62 (11), p.e434-e441 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e441 |
|---|---|
| container_issue | 11 |
| container_start_page | e434 |
| container_title | Journal of plastic, reconstructive & aesthetic surgery |
| container_volume | 62 |
| creator | Arnáiz-García, M.E Alonso-Peña, D del Carmen González-Vela, M García-Palomo, J.D Sanz-Giménez-Rico, J.R Arnáiz-García, A.M |
| description | Summary Mucormycosis is a highly aggressive fungal infection caused by Zygomycetes, from the order of Mucorales. This infection commonly presents an aggressive and rapid course and typically affects immunocompromised patients. Mucormycosis can manifest in different clinical patterns and locations. Although the correct diagnosis is often difficult, an early identification is essential for patient survival. Several clinical forms of mucormycosis are recognised. Cutaneous mucormycosis is less common than other clinical forms, but potentially lethal if treatment is not rapid. Tissue examination by histopathology and culture confirms the fungal infection. Standard treatment includes antifungal therapies associated with surgical debridement. We report five different cases of cutaneous mucormycosis treated in our institution and the management carried out in each case. |
| doi_str_mv | 10.1016/j.bjps.2008.04.040 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_734240360</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1748681508006256</els_id><sourcerecordid>734240360</sourcerecordid><originalsourceid>FETCH-LOGICAL-c410t-3e8109d10d3db7bbd483f109dffc7e51a988688f4a6cd3ea8b2de79760b2413b3</originalsourceid><addsrcrecordid>eNp9kV1L5DAUhoOs-P0HvJDe7VXHkyZNM7IsyOAXCF6o1yFNTjG1bcakVebfmzIDC3shHEjIed-XnOcQck5hQYGKy3ZRt-u4KADkAngq2CNHVFYyh5Itf6V7xWUuJC0PyXGMLQBnlJcH5JBKIbmQcEQeVtOoB_RTzPrJ-NBvjI8uXmUB1z6MmW-yxn1iZnTEmOnBpsanw6-5Mb5h1rkRgx6ngKdkv9FdxLPdeUJeb29eVvf549Pdw-r6MTecwpgzlBSWloJltq7q2nLJmvmlaUyFJdVLmT4nG66FsQy1rAuL1bISUBecspqdkN_b3HXwHxPGUfUuGuy67RiqYrzgwAQkZbFVmuBjDNiodXC9DhtFQc0EVatmgmomqICnmk0Xu_ip7tH-s-yQJcGfrQDTkAlFUNE4HAxaF9CMynr3c_7f_-ymc4MzunvHDcbWT2FI-BRVsVCgnucdzisECSCKUrBvvmyXVg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>734240360</pqid></control><display><type>article</type><title>Cutaneous mucormycosis: report of five cases and review of the literature</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Arnáiz-García, M.E ; Alonso-Peña, D ; del Carmen González-Vela, M ; García-Palomo, J.D ; Sanz-Giménez-Rico, J.R ; Arnáiz-García, A.M</creator><creatorcontrib>Arnáiz-García, M.E ; Alonso-Peña, D ; del Carmen González-Vela, M ; García-Palomo, J.D ; Sanz-Giménez-Rico, J.R ; Arnáiz-García, A.M</creatorcontrib><description>Summary Mucormycosis is a highly aggressive fungal infection caused by Zygomycetes, from the order of Mucorales. This infection commonly presents an aggressive and rapid course and typically affects immunocompromised patients. Mucormycosis can manifest in different clinical patterns and locations. Although the correct diagnosis is often difficult, an early identification is essential for patient survival. Several clinical forms of mucormycosis are recognised. Cutaneous mucormycosis is less common than other clinical forms, but potentially lethal if treatment is not rapid. Tissue examination by histopathology and culture confirms the fungal infection. Standard treatment includes antifungal therapies associated with surgical debridement. We report five different cases of cutaneous mucormycosis treated in our institution and the management carried out in each case.</description><identifier>ISSN: 1748-6815</identifier><identifier>EISSN: 1878-0539</identifier><identifier>DOI: 10.1016/j.bjps.2008.04.040</identifier><identifier>PMID: 18684680</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Adult ; Aged ; Antifungal Agents - therapeutic use ; Antifungal therapy ; Combined Modality Therapy ; Cutaneous mucormycosis ; Debridement - methods ; Dermatomycoses - diagnosis ; Dermatomycoses - immunology ; Dermatomycoses - therapy ; Follow-Up Studies ; Humans ; Hyperbaric Oxygenation - methods ; Immunocompromised Host ; Immunohistochemistry ; Male ; Mucormycosis - diagnosis ; Mucormycosis - immunology ; Mucormycosis - therapy ; Plastic Surgery ; Risk Assessment ; Sampling Studies ; Severity of Illness Index ; Skin Transplantation - methods ; Surgical treatment ; Treatment Outcome ; Wound Healing - physiology ; Young Adult</subject><ispartof>Journal of plastic, reconstructive & aesthetic surgery, 2009-11, Vol.62 (11), p.e434-e441</ispartof><rights>British Association of Plastic, Reconstructive and Aesthetic Surgeons</rights><rights>2009 British Association of Plastic, Reconstructive and Aesthetic Surgeons</rights><rights>(c) 2009 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c410t-3e8109d10d3db7bbd483f109dffc7e51a988688f4a6cd3ea8b2de79760b2413b3</citedby><cites>FETCH-LOGICAL-c410t-3e8109d10d3db7bbd483f109dffc7e51a988688f4a6cd3ea8b2de79760b2413b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bjps.2008.04.040$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18684680$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Arnáiz-García, M.E</creatorcontrib><creatorcontrib>Alonso-Peña, D</creatorcontrib><creatorcontrib>del Carmen González-Vela, M</creatorcontrib><creatorcontrib>García-Palomo, J.D</creatorcontrib><creatorcontrib>Sanz-Giménez-Rico, J.R</creatorcontrib><creatorcontrib>Arnáiz-García, A.M</creatorcontrib><title>Cutaneous mucormycosis: report of five cases and review of the literature</title><title>Journal of plastic, reconstructive & aesthetic surgery</title><addtitle>J Plast Reconstr Aesthet Surg</addtitle><description>Summary Mucormycosis is a highly aggressive fungal infection caused by Zygomycetes, from the order of Mucorales. This infection commonly presents an aggressive and rapid course and typically affects immunocompromised patients. Mucormycosis can manifest in different clinical patterns and locations. Although the correct diagnosis is often difficult, an early identification is essential for patient survival. Several clinical forms of mucormycosis are recognised. Cutaneous mucormycosis is less common than other clinical forms, but potentially lethal if treatment is not rapid. Tissue examination by histopathology and culture confirms the fungal infection. Standard treatment includes antifungal therapies associated with surgical debridement. We report five different cases of cutaneous mucormycosis treated in our institution and the management carried out in each case.</description><subject>Adult</subject><subject>Aged</subject><subject>Antifungal Agents - therapeutic use</subject><subject>Antifungal therapy</subject><subject>Combined Modality Therapy</subject><subject>Cutaneous mucormycosis</subject><subject>Debridement - methods</subject><subject>Dermatomycoses - diagnosis</subject><subject>Dermatomycoses - immunology</subject><subject>Dermatomycoses - therapy</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Hyperbaric Oxygenation - methods</subject><subject>Immunocompromised Host</subject><subject>Immunohistochemistry</subject><subject>Male</subject><subject>Mucormycosis - diagnosis</subject><subject>Mucormycosis - immunology</subject><subject>Mucormycosis - therapy</subject><subject>Plastic Surgery</subject><subject>Risk Assessment</subject><subject>Sampling Studies</subject><subject>Severity of Illness Index</subject><subject>Skin Transplantation - methods</subject><subject>Surgical treatment</subject><subject>Treatment Outcome</subject><subject>Wound Healing - physiology</subject><subject>Young Adult</subject><issn>1748-6815</issn><issn>1878-0539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kV1L5DAUhoOs-P0HvJDe7VXHkyZNM7IsyOAXCF6o1yFNTjG1bcakVebfmzIDC3shHEjIed-XnOcQck5hQYGKy3ZRt-u4KADkAngq2CNHVFYyh5Itf6V7xWUuJC0PyXGMLQBnlJcH5JBKIbmQcEQeVtOoB_RTzPrJ-NBvjI8uXmUB1z6MmW-yxn1iZnTEmOnBpsanw6-5Mb5h1rkRgx6ngKdkv9FdxLPdeUJeb29eVvf549Pdw-r6MTecwpgzlBSWloJltq7q2nLJmvmlaUyFJdVLmT4nG66FsQy1rAuL1bISUBecspqdkN_b3HXwHxPGUfUuGuy67RiqYrzgwAQkZbFVmuBjDNiodXC9DhtFQc0EVatmgmomqICnmk0Xu_ip7tH-s-yQJcGfrQDTkAlFUNE4HAxaF9CMynr3c_7f_-ymc4MzunvHDcbWT2FI-BRVsVCgnucdzisECSCKUrBvvmyXVg</recordid><startdate>20091101</startdate><enddate>20091101</enddate><creator>Arnáiz-García, M.E</creator><creator>Alonso-Peña, D</creator><creator>del Carmen González-Vela, M</creator><creator>García-Palomo, J.D</creator><creator>Sanz-Giménez-Rico, J.R</creator><creator>Arnáiz-García, A.M</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20091101</creationdate><title>Cutaneous mucormycosis: report of five cases and review of the literature</title><author>Arnáiz-García, M.E ; Alonso-Peña, D ; del Carmen González-Vela, M ; García-Palomo, J.D ; Sanz-Giménez-Rico, J.R ; Arnáiz-García, A.M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c410t-3e8109d10d3db7bbd483f109dffc7e51a988688f4a6cd3ea8b2de79760b2413b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antifungal Agents - therapeutic use</topic><topic>Antifungal therapy</topic><topic>Combined Modality Therapy</topic><topic>Cutaneous mucormycosis</topic><topic>Debridement - methods</topic><topic>Dermatomycoses - diagnosis</topic><topic>Dermatomycoses - immunology</topic><topic>Dermatomycoses - therapy</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Hyperbaric Oxygenation - methods</topic><topic>Immunocompromised Host</topic><topic>Immunohistochemistry</topic><topic>Male</topic><topic>Mucormycosis - diagnosis</topic><topic>Mucormycosis - immunology</topic><topic>Mucormycosis - therapy</topic><topic>Plastic Surgery</topic><topic>Risk Assessment</topic><topic>Sampling Studies</topic><topic>Severity of Illness Index</topic><topic>Skin Transplantation - methods</topic><topic>Surgical treatment</topic><topic>Treatment Outcome</topic><topic>Wound Healing - physiology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arnáiz-García, M.E</creatorcontrib><creatorcontrib>Alonso-Peña, D</creatorcontrib><creatorcontrib>del Carmen González-Vela, M</creatorcontrib><creatorcontrib>García-Palomo, J.D</creatorcontrib><creatorcontrib>Sanz-Giménez-Rico, J.R</creatorcontrib><creatorcontrib>Arnáiz-García, A.M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of plastic, reconstructive & aesthetic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arnáiz-García, M.E</au><au>Alonso-Peña, D</au><au>del Carmen González-Vela, M</au><au>García-Palomo, J.D</au><au>Sanz-Giménez-Rico, J.R</au><au>Arnáiz-García, A.M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cutaneous mucormycosis: report of five cases and review of the literature</atitle><jtitle>Journal of plastic, reconstructive & aesthetic surgery</jtitle><addtitle>J Plast Reconstr Aesthet Surg</addtitle><date>2009-11-01</date><risdate>2009</risdate><volume>62</volume><issue>11</issue><spage>e434</spage><epage>e441</epage><pages>e434-e441</pages><issn>1748-6815</issn><eissn>1878-0539</eissn><abstract>Summary Mucormycosis is a highly aggressive fungal infection caused by Zygomycetes, from the order of Mucorales. This infection commonly presents an aggressive and rapid course and typically affects immunocompromised patients. Mucormycosis can manifest in different clinical patterns and locations. Although the correct diagnosis is often difficult, an early identification is essential for patient survival. Several clinical forms of mucormycosis are recognised. Cutaneous mucormycosis is less common than other clinical forms, but potentially lethal if treatment is not rapid. Tissue examination by histopathology and culture confirms the fungal infection. Standard treatment includes antifungal therapies associated with surgical debridement. We report five different cases of cutaneous mucormycosis treated in our institution and the management carried out in each case.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>18684680</pmid><doi>10.1016/j.bjps.2008.04.040</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1748-6815 |
| ispartof | Journal of plastic, reconstructive & aesthetic surgery, 2009-11, Vol.62 (11), p.e434-e441 |
| issn | 1748-6815 1878-0539 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_734240360 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Adult Aged Antifungal Agents - therapeutic use Antifungal therapy Combined Modality Therapy Cutaneous mucormycosis Debridement - methods Dermatomycoses - diagnosis Dermatomycoses - immunology Dermatomycoses - therapy Follow-Up Studies Humans Hyperbaric Oxygenation - methods Immunocompromised Host Immunohistochemistry Male Mucormycosis - diagnosis Mucormycosis - immunology Mucormycosis - therapy Plastic Surgery Risk Assessment Sampling Studies Severity of Illness Index Skin Transplantation - methods Surgical treatment Treatment Outcome Wound Healing - physiology Young Adult |
| title | Cutaneous mucormycosis: report of five cases and review of the literature |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T07%3A00%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cutaneous%20mucormycosis:%20report%20of%20five%20cases%20and%20review%20of%20the%20literature&rft.jtitle=Journal%20of%20plastic,%20reconstructive%20&%20aesthetic%20surgery&rft.au=Arn%C3%A1iz-Garc%C3%ADa,%20M.E&rft.date=2009-11-01&rft.volume=62&rft.issue=11&rft.spage=e434&rft.epage=e441&rft.pages=e434-e441&rft.issn=1748-6815&rft.eissn=1878-0539&rft_id=info:doi/10.1016/j.bjps.2008.04.040&rft_dat=%3Cproquest_cross%3E734240360%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=734240360&rft_id=info:pmid/18684680&rft_els_id=S1748681508006256&rfr_iscdi=true |